Cationic Nanoparticle-Based Cancer Vaccines
Cationic nanoparticles have been shown to be surprisingly effective as cancer vaccine vehicles in preclinical and clinical studies. Cationic nanoparticles deliver tumor-associated antigens to dendritic cells and induce immune activation, resulting in strong antigen-specific cellular immune responses...
Main Authors: | Jeroen Heuts, Wim Jiskoot, Ferry Ossendorp, Koen van der Maaden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/596 |
Similar Items
-
Translational nanoparticle engineering for cancer vaccines
by: Adam J. Grippin, et al.
Published: (2017-10-01) -
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
by: Zili Gu, et al.
Published: (2020-11-01) -
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
by: Thai Thanh Hoang Thi, et al.
Published: (2021-04-01) -
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
by: Elias J. Sayour, et al.
Published: (2018-09-01) -
Re-programming Immunity Against Glioblastoma via RNA Nanoparticle Vaccines
by: Sayour, Elias Joseph
Published: (2015)